City

Beijing (1)

Maastricht (1)

Overall Status

Not yet recruiting (2)

Recruiting (1)

Withdrawn (1)

Sign in for free

Phase

n/a (1)

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Volastra Therapeutics, Inc. (2)

Lei Li (1)

Maastricht University Medical Center (1)

Collaborator

Intervention

follow up (1)

sovilnesib (1)

surgery (1)

testing for chromosomal instability (cin) (1)

vls-1488 (1)

Study Documents

Intervention Type

drug (2)

diagnostic test (1)

other (1)

procedure (1)

Funder Type

Industry (2)

Other (2)

Study Type

Interventional (3)

Observational (1)

chromosomal instability

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

High Grade Serous Adenocarcinoma of Ovary, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial (Sovilnesib)

Not yet recruiting

High Grade Serous Adenocarcinoma of Ovary
+3 more

Sovilnesib

(no location specified)

Oct 13, 2023

Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary, Squamous Non-small-cell Lung Cancer Trial (VLS-1488)

Not yet recruiting

Advanced Solid Tumor
+15 more

VLS-1488

(no location specified)

Jun 2, 2023

Chromosomal Instability in Ovarian Cancer

Recruiting

Epithelial Ovarian Cancer
+7 more

Testing for chromosomal instability (CIN)

Beijing, Beijing, China

Lei Li

Mar 26, 2022

Chromosomal Instability, Low Grade Dysplasia Oral Cavity, Loss of Heterozygostiy Trial in Maastricht (surgery, follow up)

Withdrawn

Chromosomal Instability
+3 more

surgery
follow up

Maastricht, Limburg, Netherlands

Maastricht Universitair Medisch Centrum (MUMC)

Jan 5, 2018